Optim.AI™ is a revolutionary technology that efficiently solves large & complex search spaces
Optim.AI™ works across models and routinely processes patient samples
Optim.AI™ can evaluate functional drug responses with two types of assays.
Leverage our Optim.AI™ technology in stand alone or integrated research studies
for drug research
Measure data via ATP cell viability or high content image- based assays
Data can be generated with cell lines, PDOs, PDXs, Primary Patient Samples
Combine genomics, transcriptomics, and functionomics to further enhance research studies
Each test yields >500K drug-dose data points
Our platform has been validated with >80% accuracy across cancer types
